Embree Financial Group Lowers Position in SPDR S&P Biotech ETF $XBI

Embree Financial Group decreased its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 23.6% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,294 shares of the exchange traded fund’s stock after selling 1,020 shares during the period. Embree Financial Group’s holdings in SPDR S&P Biotech ETF were worth $273,000 as of its most recent filing with the SEC.

A number of other large investors have also added to or reduced their stakes in the stock. Provident Wealth Management LLC increased its position in SPDR S&P Biotech ETF by 3,000.0% in the first quarter. Provident Wealth Management LLC now owns 310 shares of the exchange traded fund’s stock worth $25,000 after buying an additional 300 shares during the last quarter. Garrison Bradford & Associates Inc. purchased a new stake in SPDR S&P Biotech ETF in the 1st quarter worth about $39,000. Compass Wealth Management LLC increased its holdings in SPDR S&P Biotech ETF by 46.0% in the 1st quarter. Compass Wealth Management LLC now owns 635 shares of the exchange traded fund’s stock worth $51,000 after acquiring an additional 200 shares during the last quarter. Golden State Wealth Management LLC increased its stake in shares of SPDR S&P Biotech ETF by 100.0% in the first quarter. Golden State Wealth Management LLC now owns 638 shares of the exchange traded fund’s stock worth $52,000 after purchasing an additional 319 shares in the last quarter. Finally, Avalon Trust Co purchased a new position in shares of SPDR S&P Biotech ETF in the first quarter worth about $57,000.

SPDR S&P Biotech ETF Stock Down 1.6%

XBI stock opened at $95.86 on Friday. The firm has a market capitalization of $5.22 billion, a PE ratio of 11.47 and a beta of 0.97. SPDR S&P Biotech ETF has a twelve month low of $66.66 and a twelve month high of $105.47. The stock has a 50-day simple moving average of $90.44 and a two-hundred day simple moving average of $84.58.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.